Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1Mirikizumab[1] Mirikizumab (Mirikizumab)[1] Mirikizumab (Mirikizumab, Mirikizumab-mrkz) 💬 [1] IL23A 💬 [9] C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬[3] 37, 96, 97 💬
2Mirikizumab (MIR)[1] Mirikizumab (Mirikizumab)[1] Mirikizumab (Mirikizumab, Mirikizumab-mrkz) 💬 [1] IL23A 💬 [9] C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬[1] 96 💬
3Mirikizumab - Intravenous (IV)[1] Mirikizumab (Mirikizumab)[1] Mirikizumab (Mirikizumab, Mirikizumab-mrkz) 💬 [1] IL23A 💬 [9] C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬[2] 96, 97 💬
4Mirikizumab - IV[1] Mirikizumab (Mirikizumab)[1] Mirikizumab (Mirikizumab, Mirikizumab-mrkz) 💬 [1] IL23A 💬 [9] C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬[1] 96 💬
5Mirikizumab - SC[1] Mirikizumab (Mirikizumab)[1] Mirikizumab (Mirikizumab, Mirikizumab-mrkz) 💬 [1] IL23A 💬 [9] C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬[1] 96 💬
6Mirikizumab - Subcutaneous (SC)[1] Mirikizumab (Mirikizumab)[1] Mirikizumab (Mirikizumab, Mirikizumab-mrkz) 💬 [1] IL23A 💬 [9] C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬[2] 96, 97 💬
7Mirikizumab IV[1] Mirikizumab (Mirikizumab)[1] Mirikizumab (Mirikizumab, Mirikizumab-mrkz) 💬 [1] IL23A 💬 [9] C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬[1] 97 💬
8Mirikizumab SC[1] Mirikizumab (Mirikizumab)[1] Mirikizumab (Mirikizumab, Mirikizumab-mrkz) 💬 [1] IL23A 💬 [9] C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬[1] 97 💬